Latest Mergers And Acquisitions News

Delta Lithium reports robust December quarter results with significant gold drilling successes at Mt Ida and progress on lithium development at Yinnetharra, alongside strategic leadership changes and asset sales.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Uvre Limited has completed a key Phase 2 geophysical survey at its Frome Downs Uranium Project in South Australia and secured a Heritage Survey Agreement, setting the stage for its inaugural drilling program.

Perpetual Limited's Q2 FY25 update reveals a 3.6% rise in Assets Under Management to A$230.2 billion, buoyed by currency tailwinds despite net outflows and market headwinds. Corporate Trust and Wealth Management also posted modest growth, setting the stage for the upcoming half-year results.

Asset Vision Co Limited has reported a robust Q2 FY25, marked by significant revenue growth, improved cash flow, and effective cost management, positioning the company well for continued expansion.

Mad Paws Holdings Limited reported a milestone positive cash EBITDA of $0.3 million in Q2 FY25, driven by strong marketplace growth and operational efficiencies. The company is amplifying its market presence with a $5.25 million brand campaign in partnership with Seven West Media.

Patrys Limited has halted plans for a Phase 1 trial of PAT-DX1 following disappointing GMP production results, pivoting its development efforts towards PAT-DX3 and exploring new partnerships.

BlueBet Holdings has delivered positive EBITDA for the first half of FY25 ahead of schedule, driven by strategic customer reactivation and enhanced platform efficiencies following its merger with betr.

SciDev Ltd reports a seasonal revenue dip in Q2 FY25 due to US Oil & Gas sector uncertainty but marks a strategic milestone by securing its first PFAS treatment contracts in Europe.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.

Rimfire Pacific Mining's December 2024 quarterly report reveals its highest-grade scandium intercept to date at Murga and strategic expansion with the Rabbit Trap Scandium Project acquisition, alongside promising cobalt-copper results at Broken Hill.

Mad Paws Holdings Limited has reported a strong Q2 FY25 with a 328% increase in cash EBITDA and a 16% rise in marketplace revenue, driven by a strategic above-the-line marketing campaign.